CNTN
Tharimmune, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.29
+1.56%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.7x
Market Cap
$182.07M
MomentumView details →
1D Return
+1.56%
YTD Return
−25.25%
RSI (14)
54.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.7x
Market Cap
$182.07M
RSI (14)
54.1
MomentumView details →
1D Return
+1.56%
YTD Return
−25.25%
Similar companies
Latest newsMore news →
Canton Strategic Holdings, Inc. released its financial and operating results for the second quarter ended June 30, 2026, reporting first operating revenue from locking service and Super Validator operations and completing the sale of its legacy biotechnology subsidiary Gravitas.21d agoTheeb Rent A Car secured board approval on 5 August 2026 to establish a new limited liability subsidiary in Bahrain, 99% owned by the company and 1% by CEO Naif Mohammed Al Theeb, to provide car rental services in the Bahraini market.29d agoCanton Strategic Holdings, Inc. elected Sean Galvin, Pamela L. Carter, and Rishi Nangalia as directors to its Board of Directors, effective July 13, 2026.38d ago